| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Rüffert, M Wehner, C Deutrich, D Olthof. [Malignant hyperthermia. The ugly]. Der Anaesthesist. vol 56. issue 9. 2008-01-02. PMID:17565473. |
the neuroleptic malignant syndrome or the serotonin syndrome. |
2008-01-02 |
2023-08-12 |
Not clear |
| Yukihiro Hamada, Katsuichi Miyamoto, Yohei Inatsugi, Hidekazu Suzuki, Susumu Kusunok. [A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine]. Rinsho shinkeigaku = Clinical neurology. vol 46. issue 8. 2007-02-12. PMID:17154040. |
we present a first case of parkinson's disease with neuroleptic malignant syndrome by paroxetine, one of the selective serotonin reuptake inhibitor (ssri). |
2007-02-12 |
2023-08-12 |
Not clear |
| Peter W Kaplan, Gretchen Birbec. Lithium-induced confusional states: nonconvulsive status epilepticus or triphasic encephalopathy? Epilepsia. vol 47. issue 12. 2007-01-24. PMID:17201705. |
lithium therapy can cause a confusional state by direct toxicity, precipitation of nonconvulsive status epilepticus, or by interplay with other neuroleptic medications to produce neuroleptic malignant syndrome or serotonin syndrome. |
2007-01-24 |
2023-08-12 |
Not clear |
| Kenneth R Kaufman, Michael J Levitt, John F Schiltz, Jagadeeshan Sunderra. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 18. issue 3. 2007-01-18. PMID:16923659. |
neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis. |
2007-01-18 |
2023-08-12 |
Not clear |
| Kenneth R Kaufman, Michael J Levitt, John F Schiltz, Jagadeeshan Sunderra. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 18. issue 3. 2007-01-18. PMID:16923659. |
serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) are medical emergencies associated with psychotropic administration. |
2007-01-18 |
2023-08-12 |
Not clear |
| Jason Vena, Susan Dufel, Todd Paig. Acute olanzapine-induced akathisia and dystonia in a patient discontinued from fluoxetine. The Journal of emergency medicine. vol 30. issue 3. 2006-10-12. PMID:16677985. |
the possibility of neuroleptic malignant syndrome (nms), serotonin syndrome (ss), tricyclic overdose, and cocaine abuse should be considered in a patient with extrapyramidal signs and symptoms, given the potential for complications. |
2006-10-12 |
2023-08-12 |
Not clear |
| I M K ter Haar, R J Rutgers, P H M Egber. [A young woman with a labile mood, hyperactivity, hyperthermia and exhaustion: symptoms of lethal catatonia]. Nederlands tijdschrift voor geneeskunde. vol 150. issue 32. 2006-09-25. PMID:16948232. |
lethal catatonia must be distinguished from the neuroleptic malignant syndrome, serotonin syndrome and encephalitis. |
2006-09-25 |
2023-08-12 |
Not clear |
| Karl Marlowe, Dorothea Schirge. Quetiapine and citalopram: aetiological significances in serotonin syndrome. The New Zealand medical journal. vol 119. issue 1237. 2006-08-10. PMID:16862204. |
the symptom profile of serotonin syndrome overlaps with neuroleptic malignant syndrome, but can be reliably differentiated using a time and toxicity scale. |
2006-08-10 |
2023-08-12 |
Not clear |
| Daniel E Rusyniak, Jon E Spragu. Hyperthermic syndromes induced by toxins. Clinics in laboratory medicine. vol 26. issue 1. 2006-05-25. PMID:16567230. |
in this article, the authors discuss serotonin and sympathomimetic syndromes, neuroleptic malignant syndrome,and malignant hyperthermia and how these syndromes affect the hypothalamic and sympathetic nervous systems, resulting at times in severe hyperthermia. |
2006-05-25 |
2023-08-12 |
Not clear |
| Robert L Rodnitzk. Drug-induced movement disorders in children and adolescents. Expert opinion on drug safety. vol 4. issue 1. 2006-02-14. PMID:15709901. |
within these three categories, this review discusses the epidemiology, risk factors, clinical features and treatment of acute dystonic reactions, drug-induced parkinsonism, neuroleptic malignant syndrome, serotonin syndrome, acute akathisia, and the tardive syndromes. |
2006-02-14 |
2023-08-12 |
Not clear |
| Daniel E Rusyniak, Jon E Spragu. Toxin-induced hyperthermic syndromes. The Medical clinics of North America. vol 89. issue 6. 2005-12-22. PMID:16227063. |
in those patients in whom it is difficult to differentiate between serotonin and neuroleptic malignant syndromes, the physical examination may be helpful:clonus and hyperreflexia are more suggestive of serotonin syndrome,whereas lead-pipe rigidity is suggestive of nms. |
2005-12-22 |
2023-08-12 |
Not clear |
| D Gaasbeek, P Naarding, T Stor, H P H Kreme. Drug-induced hyperthermia in Huntington's disease. Journal of neurology. vol 251. issue 4. 2005-03-01. PMID:15083292. |
we describe four cases with advanced stage huntington's disease who within a period of one year developed drug-induced hyperthermia, either the neuroleptic malignant syndrome, or the serotonin syndrome. |
2005-03-01 |
2023-08-12 |
Not clear |
| Lindara L Halloran, David W Bernar. Management of drug-induced hyperthermia. Current opinion in pediatrics. vol 16. issue 2. 2004-06-25. PMID:15021205. |
specifically, five syndromes will be discussed: malignant hyperthermia, neuroleptic malignant syndrome, anticholinergic poisoning, sympathomimetic poisoning, and serotonin syndrome. |
2004-06-25 |
2023-08-12 |
Not clear |
| Robert L Rodnitzk. Drug-induced movement disorders in children. Seminars in pediatric neurology. vol 10. issue 1. 2003-11-19. PMID:12785751. |
unlike the isolated abnormal involuntary movements associated with drugs prescribed for epilepsy or asthma, movement syndromes (eg, acute dystonic reaction, neuroleptic malignant syndrome, serotonin syndrome, tardive dyskinesia) associated with psychotropic drugs are complex, difficult to recognize, and potentially seriously disabling. |
2003-11-19 |
2023-08-12 |
Not clear |
| Rasih Atilla Ener, Sharon B Meglathery, William A Van Decker, Rollin M Gallaghe. Serotonin syndrome and other serotonergic disorders. Pain medicine (Malden, Mass.). vol 4. issue 1. 2003-10-02. PMID:12873279. |
the frequent concurrent use of serotonergic and neuroleptic drugs and similarities between serotonin syndrome and neuroleptic malignant syndrome can present the clinician with a diagnostic challenge. |
2003-10-02 |
2023-08-12 |
Not clear |
| M Fink, M A Taylo. The many varieties of catatonia. European archives of psychiatry and clinical neuroscience. vol 251 Suppl 1. 2002-03-07. PMID:11776271. |
the commonality in response indicates that catatonia, malignant catatonia, neuroleptic malignant syndrome, toxic serotonin syndrome, delirious mania, catatonic excitement, benign stupor, and oneirophrenia are best evaluated as diverse manifestations of one syndrome for clinical and neuroscience research purposes. |
2002-03-07 |
2023-08-12 |
Not clear |
| G K Isbister, A Dawson, I M Whyt. Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome? Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 46. issue 7. 2001-12-07. PMID:11582830. |
citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome? |
2001-12-07 |
2023-08-12 |
Not clear |
| E A McGuga. Hyperpyrexia in the emergency department. Emergency medicine (Fremantle, W.A.). vol 13. issue 1. 2001-08-30. PMID:11476402. |
it includes sepsis, heat illness including heat stroke, neuroleptic malignant syndrome, malignant hyperthermia, serotonin syndrome and thyroid storm. |
2001-08-30 |
2023-08-12 |
Not clear |
| B Spivak, D I Maline, Y Vered, V N Kozyrev, R Mester, S A Neduva, R S Ravilov, E Graff, A Weizma. Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome. Acta psychiatrica Scandinavica. vol 102. issue 3. 2001-02-02. PMID:11008859. |
prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome. |
2001-02-02 |
2023-08-12 |
Not clear |
| O D López Gastón, S Wierzbinsky, R S López Gastón, S Resnik, S Pardoménico, M Jorg. [Sertraline. Adverse effects due to the superposition of serotonic and malignant neuroleptic syndromes]. Medicina. vol 60. issue 2. 2000-09-20. PMID:10962817. |
differential diagnosis between the neuroleptic malignant syndrome and the serotonin syndrome could not be determined accurately because of the striking overlap of signs and symptoms of both syndromes. |
2000-09-20 |
2023-08-12 |
Not clear |